| Name | Title | Contact Details |
|---|
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
https://t.co/QHy4u1rf0W is a next-gen mental wellness company that believes in the power of psychedelics to catalyze lasting change.
DermOne is a leading dermatology practice management support organization providing unparalleled business and administrative support services to dermatologists across the United States. At DermOne, we are focused on affiliating with exceptional dermatologists who are committed to delivering innovative solutions and unsurpassed care to keep patients’ skin healthy and beautiful. DermOne’s proven practice support model allows dermatologists to focus on what they enjoy most – taking great care of patients - while benefitting from DermOne’s business expertise, state of the art systems, and shared best practices. Our philosophy is simple – if we take great care of physicians, they in turn can take great care of patients. DermOne is expanding its team of affiliated physicians, a group with diverse experience and expertise who is committed to providing the very highest standard of care for all skin, hair and nail conditions. Supported by DermOne’s Chief Medical Officer and a nationally recognized Clinical Advisory Board, DermOne affiliated physicians are part of a professional, evidence-based community with access to the latest tools, advanced treatment protocols and technologies. DermOne fosters true teamwork and collaboration, while ensuring physicians maintain autonomy in all clinical decision making. Each of DermOne’s affiliated physicians provide comprehensive, compassionate care – delivered expertly and professionally. This commitment is honored in all of the clinical services provided, including: complex medical and surgical dermatology, pediatric and adolescent dermatology, cosmetic dermatology, Mohs micrographic skin cancer surgery, facial plastic and reconstructive surgery, and vein care. Schedule an appointment at any of DermOne’s affiliated practice locations. One of our affiliated physicians looks forward to caring for you.
Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care hospitals and affiliate relationships with several rural hospitals. It is the largest nongovernmental employer in the region, employing more than 6,500 people.